Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Garey

Showing results (31-40 of 300) with videos related to

Pageof 30
Sort By:
Pharmacy World & Science : PWS|July 8, 2005
Treatment failures secondary to drug interactions with divalent cations and fluoroquinoloneKatie J Suda, Kevin W Garey, Larry H Danziger
The Annals of Pharmacotherapy|April 30, 1998
Azathioprine hypersensitivity reaction in a patient with ulcerative colitisK W Garey, D S Streetman, M C Rainish
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 25, 2024
Erratum to "Development and validation of LC-MS/MS for quantifying omadacycline from stool for gut microbiome studies" [J. Chromatogr. B 1236 (2024) 124057]Chenlin Hu, Weiqun Wang, Jinhee Jo, et al.
Seminars in Respiratory and Critical Care Medicine|February 16, 2022
Fulminant Clostridioides difficile Infection: A Review of Treatment Options for a Life-Threatening InfectionTravis J Carlson, Anne J Gonzales-Luna, Kevin W Garey
Chest|January 16, 2003
Tissue reparative effects of macrolide antibiotics in chronic inflammatory sinopulmonary diseasesKevin W Garey, Anita Alwani, Larry H Danziger, et al.
American Journal of Infection Control|February 24, 2019
Economic health care costs of blood culture contamination: A systematic reviewCasey Dempsey, Erik Skoglund, Kenneth L Muldrew, et al.
Antimicrobial Agents and Chemotherapy|June 6, 2012
Inhibition of biofilm formation by esomeprazole in Pseudomonas aeruginosa and Staphylococcus aureusVandana Singh, Vaneet Arora, M Jahangir Alam, et al.
The Journal of Hospital Infection|October 28, 2008
Meta-analysis to assess risk factors for recurrent Clostridium difficile infectionK W Garey, S Sethi, Y Yadav, et al.
The Journal of Infection|September 9, 2009
Clostridium difficile-related death rates in Texas 1999-2005Miguel Salazar, Lyudmila Baskin, Kevin W Garey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2023
Review Article: Safety of Live Biotherapeutic Products Used for the Prevention of Clostridioides difficile Infection RecurrenceAnne J Gonzales-Luna, Travis J Carlson, Kevin W Garey
Pageof 30

Showing results (31-40 of 300) with videos related to

Sort By:
Pageof 30
Pharmacy World & Science : PWS|July 8, 2005
Treatment failures secondary to drug interactions with divalent cations and fluoroquinoloneKatie J Suda, Kevin W Garey, Larry H Danziger
The Annals of Pharmacotherapy|April 30, 1998
Azathioprine hypersensitivity reaction in a patient with ulcerative colitisK W Garey, D S Streetman, M C Rainish
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 25, 2024
Erratum to "Development and validation of LC-MS/MS for quantifying omadacycline from stool for gut microbiome studies" [J. Chromatogr. B 1236 (2024) 124057]Chenlin Hu, Weiqun Wang, Jinhee Jo, et al.
Seminars in Respiratory and Critical Care Medicine|February 16, 2022
Fulminant Clostridioides difficile Infection: A Review of Treatment Options for a Life-Threatening InfectionTravis J Carlson, Anne J Gonzales-Luna, Kevin W Garey
Chest|January 16, 2003
Tissue reparative effects of macrolide antibiotics in chronic inflammatory sinopulmonary diseasesKevin W Garey, Anita Alwani, Larry H Danziger, et al.
American Journal of Infection Control|February 24, 2019
Economic health care costs of blood culture contamination: A systematic reviewCasey Dempsey, Erik Skoglund, Kenneth L Muldrew, et al.
Antimicrobial Agents and Chemotherapy|June 6, 2012
Inhibition of biofilm formation by esomeprazole in Pseudomonas aeruginosa and Staphylococcus aureusVandana Singh, Vaneet Arora, M Jahangir Alam, et al.
The Journal of Hospital Infection|October 28, 2008
Meta-analysis to assess risk factors for recurrent Clostridium difficile infectionK W Garey, S Sethi, Y Yadav, et al.
The Journal of Infection|September 9, 2009
Clostridium difficile-related death rates in Texas 1999-2005Miguel Salazar, Lyudmila Baskin, Kevin W Garey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2023
Review Article: Safety of Live Biotherapeutic Products Used for the Prevention of Clostridioides difficile Infection RecurrenceAnne J Gonzales-Luna, Travis J Carlson, Kevin W Garey
Pageof 30